It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
When mice with human tumors received doses of anti-CD47, which sets the immune system against tumor cells, the cancers shrank and disappeared.
A single drug can shrink or cure human breast, ovary, colon, bladder, brain, liver, and prostate tumors that have been transplanted into mice, researchers have found. The treatment, an antibody that blocks a "do not eat" signal normally displayed on tumor cells, coaxes the immune system to destroy the cancer cells.
A decade ago, biologist Irving Weissman of the Stanford University School of Medicine in Palo Alto, California, discovered that leukemia cells produce higher levels of a protein called CD47 than do healthy cells. CD47, he and other scientists found, is also displayed on healthy blood cells; it's a marker that blocks the immune system from destroying them as they circulate. Cancers take advantage of this flag to trick the immune system into ignoring them. In the past few years, Weissman's lab showed that blocking CD47 with an antibody cured some cases of lymphomas and leukemias in mice by stimulating the immune system to recognize the cancer cells as invaders. Now, he and colleagues have shown that the CD47-blocking antibody may have a far wider impact than just blood cancers.
"What we've shown is that CD47 isn't just important on leukemias and lymphomas," says Weissman. "It's on every single human primary tumor that we tested." Moreover, Weissman's lab found that cancer cells always had higher levels of CD47 than did healthy cells. How much CD47 a tumor made could predict the survival odds of a patient.
For many years, scientists have realised that the immune system plays a key role in cancer prevention. There is ample evidence of this, not least from patients who are immune-suppressed in some way – they are more likely than other patients to develop cancer.
The immune system has two basic ways of fighting invading pathogens and the body's own cells that have gone awry. One involves the release of free-floating proteins, or antibodies, that lock on to an invader, triggering other immune cells to come in and sweep them away.
Many organisations have tried to develop anti-cancer treatments based on antibodies, with limited success, Dr Jakobsen said. Part of the problem is that antibodies are not really designed to recognise cells. What Immunocore has done is to build a therapy around the second arm of the immune system, known as cellular immunity, where T-cells seek out and destroy invading pathogens.
"There are a lot of companies working with antibodies but we are virtually the only company in the world that has managed to work with T-cells. It has taken 20 years and from that point we are unique," Dr Jakobsen said.
Immunocore has found a way of designing small protein molecules, which it calls ImmTACs, that effectively act as double-ended glue. At one end they stick to cancer cells, strongly and very specifically, leaving healthy cells untouched. At the other end they stick to T-cells.
Sea Cucumber, commonly used in Chinese medicine has recently shown promising results in the fight against Cancer. A new study shows that the extract killed 95% of breast cancer cells, 90% of melanoma cells, 95% of liver cells and 88% of lung cancer cells in vitro. The extract also activates the immune system and impedes key metastasis.
In past studies, sea cucumber extracts have been a potent defense against pancreatic, lung, prostate, colon, breast, skin and liver cancer cells as well as leukemia and gioblastoma. Researches have credited the compound trierpenoid known as frondoside A for it’s anti cancer properties.
Even more intriguing, the compound does more than just kill cancer cells, it inhibits angiogeneis (the ability of tumors to grow new blood vessels to absord food). It also stops cancer from metastasizing by impeding cell migration and invasion. The compound also activates the immune system’s natural killers to attack cancer cells. This process has been shown against breast cancer but may apply to others since it is an immune function. This also explains why frondoside A is so effective at shrinking tumors.
Early-stage tests of the drug BMS-936558, known as an anti-PD-1 treatment, showed it was relatively safe and shrank tumors in three of the five cancer types studied, the team reported at the American Society of Clinical Oncology (ASCO) meeting on Saturday and published online in the New England Journal of Medicine.
The team saw significant tumor shrinkage in 18 percent of the 76 lung cancer patients, 28 percent of the 94 melanoma patients, and 27 percent of the 33 patients with kidney cancer.
"These are significant regression rates, especially considering the kind of patient we are treating," said Dr. Suzanne Topalian, professor of surgery and oncology at Johns Hopkins Kimmel Cancer Center, who presented the findings at the ASCO cancer meeting, noting that many of the patients in the study had been treated with at least three other drugs.
A high-powered ultrasound beam can destroy prostate cancer without causing the serious side effects that plague other treatments, a London study found.
Trials in London and Basingstoke, southeastern England, found it was possible to obliterate tumor cells without damaging delicate surrounding tissues.
Conventional surgery or radiotherapy for prostate cancer leaves half of men impotent and a fifth incontinent. The side effects are so common that many men with slow-growing tumors are advised not to have treatment.
Doctors used an experimental procedure High Intensity Focused Ultrasound (HIFU) to destroy tumors during the trial.
None of the 41 men treated had incontinence and only 10 percent had impotence, the Lancet Oncology journal reported.
Researchers at the University of Alberta, in Edmonton, Canada have cured cancer last week, yet there is a little ripple in the news or in TV. It is a simple technique using very basic drug. The method employs dichloroacetate, which is currently used to treat metabolic disorders. So, there is no concern of side effects or about their long term effects.
This drug doesn’t require a patent, so anyone can employ it widely and cheaply compared to the costly cancer drugs produced by major pharmaceutical companies.
Canadian scientists tested this dichloroacetate (DCA) on human’s cells; it killed lung, breast and brain cancer cells and left the healthy cells alone. It was tested on Rats inflicted with severe tumors; their cells shrank when they were fed with water supplemented with DCA. The drug is widely available and the technique is easy to use, why the major drug companies are not involved? Or the Media interested in this find?
In human bodies there is a natural cancer fighting human cell, the mitochondria, but they need to be triggered to be effective. Scientists used to think that these mitochondria cells were damaged and thus ineffective against cancer. So they used to focus on glycolysis, which is less effective in curing cancer and more wasteful. The drug manufacturers focused on this glycolysis method to fight cancer. This DCA on the other hand doesn’t rely on glycolysis instead on mitochondria; it triggers the mitochondria which in turn fights the cancer cells.
Scientists have identified a compound in the fruit of the native blushwood shrub that appears to "liquefy and destroy cancer with no side-effects", according to latest research.
Found deep in the remnants of a 130 million-year-old rainforest, the fruit extract may yet hold the secret antidote to Australia's No.1 killer disease.
Victoria Gordon, of EcoBiotics, an Atherton Tableland-based company, said they hoped to go to human clinical trials later this year.
Dr Gordon said a single dose injection of the extract, known as EBC-46, had been effective in 50 critically ill dogs and about a dozen cats and horses.
"This is proving to be something exceptional," she said.
"The tumour literally liquefies. There is a rapid knock-down of the tumour, it disintegrates within 24 hours and we have a rapid healing response."
"The biggest tumour we treated was the size of a Coke can in a dog, and that animal is fully healed and healthy."
Cancer cells usually evade patient's immune systems because they are not recognised as being a threat. While the immune system usually attacks foreign cells such as bacteria, tumours are formed of the patient's own cells that have malfunctioned.
Scientists have, however, found that a molecule called MUC1, which is found in high amounts on the surface of cancer cells, can be used to help the immune system detect tumours.
The new vaccine, developed by drug company Vaxil Biotheraputics along with researchers at Tel Aviv University, uses a small section of the molecule to prime the immune system so that it can identify and destroy cancer cells.
A statement from Vaxil Biotheraputics said: "ImMucin generated a robust and specific immune response in all patients which was observed after only 2-4 doses of the vaccine out of a maximum of 12 doses.
Scientists from the UK have figured out a way to turn chemicals found in the crocus flower which blooms throughout the UK into a ‘smart bomb’ of sorts when it comes to a new cancer medication. This new treatment may potentially create a drug that is capable of targeting cancerous tumors, such as associated with breast, colon, lung and prostate, without causing any side effects.
While the native British Autumn crocus has been known for a long time for its anti-inflammatory and anti-cancer properties, its chemical colchicine is unfortunately also toxic to other cells within the human body. For this reason, the use of the crocus and the chemical colchicine has not been used for medical treatments.
By attaching a chemical 'tail' to the colchicine molecule, the researchers have been able to deactivate the toxic properties until it reaches the targeted cancer. Cancer tumors contain an enzyme called MMP and this enzyme effectively removes the ‘tail’ and activates the colchicine. Once activated, the colchicine goes into action breaking up the blood vessels that feed the tumor and essential starve it. Because the drug is activated in the tumor, it does not affect outside tissue and no side effects have been noted.
Scientists claim they have cured advanced skin cancer for the first time using the patient's own cells cloned outside the body.
The 52-year-old man involved was free of melanoma two years after treatment.
US researchers, reports the New England Journal of Medicine, took cancer-fighting immune cells, made five billion copies, then put them all back.
Scientists in the UK warned that further trials would need to be done to prove how well the treatment worked.
Scientists have discovered the key to the ability of spicy foods to kill cancer cells.
They found capsaicin, an ingredient of jalapeno peppers, triggers cancer cell death by attacking mitochondria - the cells' energy-generating boiler rooms.
The research raises the possibility that other cancer drugs could be developed to target mitochondria.
The Nottingham University study features in Biochemical and Biophysical Research Communications.
The study showed that the family of molecules to which capsaicin belongs, the vanilloids, bind to proteins in the cancer cell mitochondria to trigger apoptosis, or cell death, without harming surrounding healthy cells.
Capsaicin was tested on cultures of human lung cancer cells and on pancreatic cancers.
Lead researcher Dr Timothy Bates said: "As these compounds attack the very heart of the tumour cells, we believe that we have in effect discovered a fundamental 'Achilles heel' for all cancers.
Nearly 30 years after Nobel laureate Linus Pauling famously and controversially suggested that vitamin C supplements can prevent cancer, a team of Johns Hopkins scientists have shown that in mice at least, vitamin C - and potentially other antioxidants - can indeed inhibit the growth of some tumors ¯ just not in the manner suggested by years of investigation.
The conventional wisdom of how antioxidants such as vitamin C help prevent cancer growth is that they grab up volatile oxygen free radical molecules and prevent the damage they are known to do to our delicate DNA. The Hopkins study, led by Chi Dang, M.D., Ph.D., professor of medicine and oncology and Johns Hopkins Family Professor in Oncology Research, unexpectedly found that the antioxidants' actual role may be to destabilize a tumor's ability to grow under oxygen-starved conditions. Their work is detailed this week in Cancer Cell.
"The potential anticancer benefits of antioxidants have been the driving force for many clinical and preclinical studies," says Dang. "By uncovering the mechanism behind antioxidants, we are now better suited to maximize their therapeutic use."
Australian scientists have developed a "trojan horse" therapy to combat cancer, using a bacterially-derived nano cell to penetrate and disarm the cancer cell before a second nano cell kills it with chemotherapy drugs.
The "trojan horse" therapy has the potential to directly target cancer cells with chemotherapy, rather than the current treatment that sees chemotherapy drugs injected into a cancer patient and attacking both cancer and healthy cells.
Sydney scientists Dr Jennifer MacDiarmid and Dr Himanshu Brahmbhatt, who formed EnGenelC Pty Ltd in 2001, said they had achieved 100 percent survival in mice with human cancer cells by using the "trojan horse" therapy in the past two years.
Research Professor Henry Lai and assistant research Professor Narendra Singh have exploited the chemical properties of a wormwood derivative to target breast cancer cells, with surprisingly effective results. A study in the latest issue of the journal Life Sciences describes how the derivative killed virtually all human breast cancer cells exposed to it within 16 hours.
“Not only does it appear to be effective, but it’s very selective,” Lai said. “It’s highly toxic to the cancer cells, but has a marginal impact on normal breast cells.”
The compound, artemisinin, isn’t new. It apparently was extracted from the plant Artemesia annua L., commonly known as wormwood, thousands of years ago by the Chinese, who used it to combat malaria. However, the treatment was lost over time. Artemisinin was rediscovered during an archaeological dig in the 1970s that unearthed recipes for ancient medical remedies, and has become widely used in modern Asia and Africa to fight the mosquito-borne disease.
The virus, known as adeno-associated virus type 2 (AAV2), is naturally occurring and carried by up to 80 percent of humans, but it does not cause any disease.
Researchers learned of its cancer-killing properties in 2005, after Penn State scientists observed it killing cervical cancer cells. They also found that women who carried the AAV2 virus and human papillomavirus (HPV), which causes cervical cancer, had a lower propensity to develop cervical cancer.
When combined in a lab recently, AAV2 eradicated all the breast cancer cells "within seven days," according to researchers. Better still, it proved capable of wiping out cancer cells at multiple stages, negating the need for differing treatments used today.
Topical application of saffron extract (100 mg/kg body wt) inhibited two-stage initiation/promotion dimethylbenz[a]anthracene (DMBA)-induced skin carcinogenesis and oral administration of saffron extract in the same dose restricted 20-methylchloanthrene (MCA)-induced soft tissue sarcomas in mice.
Later, it was demonstrated that saffron extract significantly prolonged (almost 3-fold) the life spans of cisplatin-treated (2 mg/kg body wt) mice and partially prevented the decrease in body weight, hemoglobin levels, and leukocyte counts.
Oral administration of saffron extract (200 mg/kg body wt) induced a dose-dependent inhibition of the growth in mice of ascite tumors derived from sarcoma-180 (S-180), Ehrlich ascites carcinoma (EAC), Dalton's lymphoma ascites (DLA), and significantly increased (2- to 3-fold) life spans of treated tumor-bearing mice.
One of the misconceptions that people have about a cell is that it contains a nucleus, a cell wall and everything inside (cytoplasm) kind of sloshes around in a liquid or gel. In fact, the inside of a cell contains a kind of scaffold made of micro-tubules, also called spindles, that have the ability to assemble and disassemble quicky. This network of rigid micro-tubules inside the cell gives it shape, structure and also has the ability to transfer organelles and various molecules to different parts within the cell, functioning like a railway system. But its most vital function is cell division.
Mebendazole is known to interfere and inhibit the assembly of the spindles, thus preventing the ability of the cells to divide. The cell eventually dies of old age or aptosis. Mebendazole is highly selective and somehow targets only cancerous cells (as well as a host of intestinal parasites). At the end of this article I will post a few of the many scientific papers acknowledging these facts.
The action of mebendazole on cancer cells does not have much to do with it being a worm killer. Other meds and herbs that kill worms would be unlikely to work for cancer. Mebendazole damages tubulin in cancer cells. It interrupts the cell cycle before the cells go into mitosis. It also stimulates apoptosis, natural cell death. It also seems to block angeogenesis, meaning it stops blood vessel growth to tumors.
The giant keyhole limpet's hemolymph carries a protein that is the essential component of a new cancer vaccine. Keyhole limpet hemocyanin (KLH) carries oxygen in limpet blood. It is an unusually large protein - near virus size - and contains many epitopes, which trigger our body to produce antibodies. When doctors inject KLH into the human bloodstream, it provokes a powerful immune response. If markers for a certain cancer are attached to KLH, the immune system can be stimulated to attack them. Unlike some synthetic alternatives, KLH is nontoxic. Researchers use the protein in cancer vaccines to "break tolerance," says Frank Oakes, the CEO of Stellar Biotechnologies, which grows limpets in a business park for aquaculture next to the Pacific Ocean in Port Hueneme, California. "Your body tolerates the cancer cell because the body believes it is a part of you," he says.
More than a dozen vaccines that use KLH are in clinical trials, and a treatment for bladder cancer is now approved for use in Europe and Asia. Stellar currently has the capacity to make between one and two kilograms of KLH a year. But if a KLH cancer vaccine is FDA-approved, Oakes says it "will increase demand by orders of magnitude."
It works 100% of the time to eradicate cancer completely, and cancer does not recur even years later. That is how researchers describe the most convincing cancer cure ever announced.
The weekly injection of just 100 billionths of a gram of a harmless glyco-protein (a naturally-produced molecule with a sugar component and a protein component) activates the human immune system and cures cancer for good, according to human studies among breast cancer and colon cancer patients, producing complete remissions lasting 4 and 7 years respectively. This glyco-protein cure is totally without side effect but currently goes unused by cancer doctors.
Normal Gc protein (also called Vitamin-D binding protein) , an abundant glyco-protein found in human blood serum, becomes the molecular switch to activate macrophages when it is converted to its active form, called Gc macrophage activating factor (Gc-MAF). Gc protein is normally activated by conversion to Gc-MAF with the help of the B and T cells (bone marrow-made and thymus gland-made white blood cells). But, as researchers explain it themselves, cancer cells secrete an enzyme known as alpha-N-acetylgalactosaminidase (also called Nagalase) that completely blocks conversion of Gc protein to Gc-MAF, preventing tumor-cell killing by the macrophages. This is the way cancer cells escape detection and destruction, by disengaging the human immune system. This also leaves cancer patients prone to infections and many then succumb to pneumonia or other infections.
The once-weekly injection of minute amounts of Gc-MAF, just 100 nanograms (billionths of a gram), activates macrophages and allows the immune system to pursue cancer cells with vigor, sufficient to produce total long-term cures in humans.
The Soursop is a flowering, evergreen tree native to tropical regions of the world. It also contains a long, prickly green fruit which happens to kill cancer up to 10,000 times more effectively than strong chemotherapy drugs, all without the nasty side effects and without harming healthy cells.
According to Cancer Research UK, Annona muricata is an active principle in an herbal remedy marketed under the brand name Triamazon. The licensing for this product in the UK is not accepted due to its enormous healing effects on the body and potential loss of profits for competing pharmaceutical cancer drugs.
This tree is low and is called graviola in Brazil, guanabana in Spanish and has the uninspiring name “soursop” in English. The fruit is very large and the subacid sweet white pulp is eaten out of hand or, more commonly, used to make fruit drinks and sherbets.
Besides being a cancer remedy, graviola is a broad spectrum antimicrobial agent for both bacterial and fungal infections, is effective against internal parasites and worms, lowers high blood pressure and is used for depression, stress and nervous disorders.
Contortrostatin (CN) is a member of a family of peptides called disintegrins that are found in snake venoms. Members of this family are distinguished by the presence of an amino acid sequence, arginine-glycine-aspartic acid (RGD), that enables them to bind to cell surface receptors called integrins found on cancer cells and newly growing (angiogenic) blood vessels in the tumor. Integrins mediate interactions between cells and their surroundings, and on cancer cells they play important roles in tumor invasion and dissemination.
Information has been published in medical journals for almost a decade, about the cancer-fighting properties of the Southern Copperheads venom. A protein in the venom called contortrostatin (CN) causes a disruption in the tumor cell's ability to adhere to and invade neighbor cells while also inhibiting the development of new blood vessels required to sustain the tumor.
CN belongs to a class of proteins known as disintegrins, called that because they disrupt the function of certain other proteins, called integrins, on the surface of cells. Integrins are involved in the adhesive phenomenon of cells. CN is effective in retarding the spread of tumor cells because it inhibits their adhesion to and invasion of normal cells in the surrounding tissue.
More than half of all human cancers have lost the p53 gene. Yet even in an era of molecularly targeted therapies scientists have had trouble figuring out how to compensate for the absence of a gene. Unlike a genetic mutation that changes the function or activity of a gene, which can be inhibited by a well-tailored drug, loss of a gene leaves nothing for the drug to target.
Thompson and his team, however, have been accumulating evidence over the last several years that p53, best known as a regulator of cell division, controls several metabolic pathways in cells. For potential cancer therapies, that means a drug that affects pathways controlled by p53 could help control p53-deficient tumors.
Significantly, the regulation of metabolic pathways by p53 is also influenced by metformin, the most widely used diabetes drug. Metformin activates the metabolic enzyme AMPK (AMP activated protein kinase), which exerts changes on cellular metabolism by affecting p53 function. Two observational studies already show that diabetic patients who take metformin have a lower rate of cancer diagnosis and mortality than other diabetics.
His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011–barring the ability to raise the required $150 million to fund the final phase of FDA clinical trials.
When Antineoplastons are approved, it will mark the first time in history a single scientist, not a pharmaceutical company, will hold the exclusive patent and distribution rights on a paradigm-shifting medical breakthrough.
Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. Various cancer survivors are presented in the film who chose these medicines instead of surgery, chemotherapy or radiation - with full disclosure of medical records to support their diagnosis and recovery - as well as systematic (non-anecdotal) FDA-supervised clinical trial data comparing Antineoplastons to other available treatments—which is published within the peer-reviewed medical literature.
One form of cancer - diffuse, intrinsic, childhood brainstem glioma has never before been cured in any scientifically controlled clinical trial in the history of medicine. Antineoplastons hold the first cures in history - dozens of them. [ANP - PubMed 2003] [ANP - PubMed 2006] [Rad & other - PubMed 2008] [Chemo/Rad - PubMed 2005]
This discovery by Kaali and Lyman in the Fall of 1990 at the Albert Einstein College of Medicine, N.Y.C. in 1990 was the centerpiece of Dr. Bob Beck's lectures on blood electrification. Kaali and Lyman re-discovered something that Dr. Robert O. Becker had also came upon in the 1970's and 80's in that direct current applied at very low voltage, delivered in the 50-100 microampere range effected amazing cellular response and achieved the de-activation of pathogenic organisms.
Preferred electrifiers must generate a 3.9 Hz (not critical) biphasic sharp-rise-time square wave, +/- 27 volt peak adjustable output, 50% duty cycle, capable of delivering several milliamperes into a low resistance load at skin surface (+/- 2000 ohm impedance) which after losses in tissue resistance delivers the necessary 50 to 100 microamperes through flowing blood.
This suppressed medical discovery is proving to neutralize or eliminate all parasites and their mycotoxins, fungi, viruses, microbes, germs, pathogens, bacteria, or any other foreign invaders in blood without drugs.
There are no known side effects to healthy cells, tissue, or fluids. Elimination of blood pathogens can be verified by examining blood under dark field/phase contrast microscopy.
Very simply, when THC connects to the CB1 or CB2 cannabinoid receptor site on the cancer cell, it causes an increase in ceramide synthesis which drives cell death. A normal healthy cell does not produce ceramide in the presence of THC, thus is not affected by the cannabinoid.
The cancer cell dies, not because of cytotoxic chemicals, but because of a tiny little shift in the mitochondria. Within most cells there is a cell nucleus, numerous mitochondria (hundreds to thousands), and various other organelles in the cytoplasm. The purpose of the mitochondria is to produce energy (ATP) for cell use. As ceramide starts to accumulate, turning up the Sphingolipid Rheostat, it increases the mitochondrial membrane pore permeability to cytochrome c, a critical protein in energy synthesis. Cytochrome c is pushed out of the mitochondria, killing the source of energy for the cell.
Ceramide also causes genotoxic stress in the cancer cell nucleus generating a protein called p53, whose job it is to disrupt calcium metabolism in the mitochondria. If this weren’t enough, ceramide disrupts the cellular lysosome, the cell’s digestive system that provides nutrients for all cell functions. Ceramide, and other sphingolipids, actively inhibit pro-survival pathways in the cell leaving no possibility at all of cancer cell survival.
The Cure for cancer is found in most fruit seeds, ultimately it is the cyanide, but there are a few things to keep in mind.
Sodium is toxic to the body. so is chlorine. if you put those two together, you get salt... hm...
the main thing to remember when you think of chemicals that are toxic is; putting two together can make one or both non-toxic while the bond exists.
also here is something else to think about: Oxygen is explosive, so is hydrogen. why would anyone, in their right mind mix those two together and spray them on a fire? you get me point...
Cyanide is toxic to the body, however, whenever included in the in the molecule (Vitamin B17) which consists of Benzdehyde, Sugar and Cyanide, it becomes non-toxic while its bonded.
Cyanide is has a strong bond to the molecule, nothing in the body can break its bond with the rest of the molecule. normal cells do have an amount of beta-glucosidase but its not enough to break bond after bond, therefore, the normal cells are not as effected as cancer cells.
In the late 20's and early 1930's, Dr. Royal Raymond Rife from San Diego, California, developed a high powered microscope which he used in conjunction with a frequency generator. Using special UV light, Rife's mircroscope was capable of 60,000x magnification! This degree of magnification allowed him to observe LIVE virus and bacteria organisms while he applied the MOR (Mortal Oscillatory Resonance) frequency from his frequency generator via plasma tube radiation of the energy. He was able to destroy all manner of disease organisms (including cancer related organisms) by merely 'tuning' the generator to the correct resonant frequency of these organisms and applying the oscillating electric fields via the plasma driven, "Beam Ray Tube". Everything in the universe, living or dead, and its own resonant frequency. If you apply this exact resonant frequency to the object or organism, it will begin vibrating until it literally shatters itself. You've all seen the wine glass and the opera singer demonstration. Same deal for microbes.
Maurice Fishbein, representing the AMA at the time, wanted to ‘buy into’ Rife’s discovery for personal gain. As Rife said ‘no’ to his offer, the once-supportive AMA establishment henceforth vilified him in print and his discoveries were driven underground. Government goon squads attempted to physically destroy all the evidence of Rife’s work. There are a handful of Rife’s Universal Microscopes in existence, but none of them complete and functional. Instead, mainstream science uses the Electron Microscope, which kills the sample with radiation in the process of viewing the sample.
The records showed that after the wound became infected with a commonplace bacterium, Streptococcus pyogenes, the patient went through several bouts of fever. With each attack of fever the tumour shrank until eventually it disappeared entirely, leaving only a large scar under the left ear. Coley surmised that the infection had stimulated the German’s immune system– as evidenced by the repeated fevers– and that it was this immune response that had caused the eradication of the cancer.
The story so convinced Coley that he– perhaps cavalierly– contrived to contaminate his next ten suitable sarcoma cases with Streptococcus. His initial approach was to inject a solution of live bacteria deep into the tumour mass on a repeated basis over several months. The first patient to undergo this treatment was a bedridden man with inoperable sarcoma in the abdominal wall, bladder, and pelvis. Using this experimental method, the patient was cured spectacularly. He staged a full recovery, and survived another twenty-six years before dying from a heart attack.
After the fatalities with the ‘live’ version of his therapy, he developed an improved fluid containing killed bacteria of two different strains, Streptococcus pyogenes and Serratia marcescens. This was based on the idea that the dead bacteria would still have the immune-stimulating capability of their living brethren (in the form of purported ‘toxins’), but not share their inconvenient tendency to cause death. His invention became variously known as ‘Coley’s Toxins’, ‘Coley’s Vaccine’, ‘Mixed Bacterial Toxins’ or ‘Coley Fluid.’ The treatment was met with considerable success, with one study in 1999 suggesting that it was at least equally as effective in treating cancer as conventional modern therapies. With due care in dosing and management of the induced fever, it was also remarkably safe.
What about megadose Vitamin C? At high enough concentrations it becomes a PRO-oxidant which makes peroxide and induces apoptosis.
What about megadose Vitamin C? At high enough concentrations it becomes a PRO-oxidant which makes peroxide and induces apoptosis.
I assume you mean Liposomal Vitamin C? Let me look into it a little bit and if it seems like a plausible cancer treatment I will add it to the list.
EDIT: ok there appear to be multiple studies backing your claim so I have added it to the list.edit on 3/2/2014 by ChaoticOrder because: (no reason given)
Yes, honey possesses "moderate antitumor and pronounced anti-metastatic effects", and can aid in inhibition of various types of cancers.
You might want to add turmeric and high dose Vitamin D?
You forgot to add Bee's Honey, one of the cheapest and most widely available options.
Thanks for the list. Will have a look more into it. I've run out of the traditional medical options after 12 years fighting.
Some of the listed ones are dubious in their claims (or at least the quotations)
You forgot to add Bee's Honey, one of the cheapest and most widely available options.
Good point, but bees honey is a bit too general for my list, I was focusing more on specific drugs, chemicals, and extracts. If there's a drug based on the active ingredient in bees honey then it would be a better candidate for the list. Plus I've also read that it's important to maintain a low sugar diet to minimize growth of the cancerous cells, but maybe the natural sugars in bees honey don't fuel cell growth the same way as other sugars.